| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-13 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.22 | 9e-06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-05 |